Notice2026-08992

Agency Information Collection Activities; Renewal of an Approved Information Collection: 391.41 CMV Driver Medication Form

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
May 7, 2026

Issuing agencies

Transportation DepartmentFederal Motor Carrier Safety Administration

Abstract

In accordance with the Paperwork Reduction Act of 1995, FMCSA announces its plan to submit the Information Collection Request (ICR) described below to the Office of Management and Budget (OMB) for review and approval and invites public comment. FMCSA requests approval to renew an ICR titled, "391.41 CMV Driver Medication Form." This Information Collection (IC) is voluntary and may be utilized by medical examiners (ME) responsible for issuing Medical Examiner's Certificates (MECs) to commercial motor vehicle (CMV) drivers. MEs that choose to use this IC do so to communicate with treating healthcare professionals who are responsible for prescribing certain medications, so that the ME fully understands the reasons the medications have been prescribed. The information obtained by the ME when utilizing this IC assists the ME in determining if the driver is medically qualified and ensures that there are no disqualifying medical conditions or underlying medical conditions and prescribed medications that could adversely affect their safe driving ability or cause incapacitation constituting a risk to the public.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 88 (Thursday, May 7, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 88 (Thursday, May 7, 2026)]
[Notices]
[Pages 24958-24959]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-08992]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2026-0760]


Agency Information Collection Activities; Renewal of an Approved 
Information Collection: 391.41 CMV Driver Medication Form

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department 
of Transportation (DOT).

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Paperwork Reduction Act of 1995, FMCSA 
announces its plan to submit the Information Collection Request (ICR) 
described below to the Office of Management and Budget (OMB) for review 
and approval and invites public comment. FMCSA requests approval to 
renew an ICR titled, ``391.41 CMV Driver Medication Form.'' This 
Information Collection (IC) is voluntary and may be utilized by medical 
examiners (ME) responsible for issuing Medical Examiner's Certificates 
(MECs) to commercial motor vehicle (CMV) drivers. MEs that choose to 
use this IC do so to communicate with treating healthcare professionals 
who are responsible for prescribing certain medications, so that the ME 
fully understands the reasons the medications have been prescribed. The 
information obtained by the ME when utilizing this IC assists the ME in 
determining if the driver is medically qualified and ensures that there 
are no disqualifying medical conditions or underlying medical 
conditions and prescribed medications that could adversely affect their 
safe driving ability or cause incapacitation constituting a risk to the 
public.

DATES: Comments on this notice must be received on or before July 6, 
2026.

ADDRESSES: You may submit comments identified by Docket Number FMCSA-
2026-0760 using any of the following methods:
    <bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>. 
Follow the online instructions for submitting comments.
    <bullet> Mail: Dockets Operations; U.S. Department of 
Transportation, 1200 New Jersey Avenue SE, W58-213, Washington, DC 
20590-0001.
    <bullet> Hand Delivery or Courier: Dockets Operations, U.S. 
Department of Transportation, 1200 New Jersey Avenue SE, W58-213, 
Washington, DC, 20590-0001 between 9 a.m. and 5 p.m. ET, Monday through 
Friday, except Federal holidays. To be sure someone is there to help 
you, please call (202) 366-9317 or (202) 366-9826 before visiting 
Dockets Operations.
    <bullet> Fax: (202) 493-2251.
    To avoid duplication, please use only one of these four methods. 
See the ``Public Participation and Request for Comments'' portion of 
the SUPPLEMENTARY INFORMATION section for instructions on submitting 
comments.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Medical 
Programs Division, DOT, FMCSA, 1200 New Jersey Avenue SE, Washington, 
DC 20590-0001; (202) 366-4001; <a href="/cdn-cgi/l/email-protection#d4b7bca6bda7a0bdbab1fabcadb0bbb7bf94b0bba0fab3bba2"><span class="__cf_email__" data-cfemail="1d7e756f746e6974737833756479727e765d797269337a726b">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION:

Instructions

    All submissions must include the Agency name and docket number. For 
detailed instructions on submitting comments, see the Public 
Participation heading below. Note that all comments received will be 
posted without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any 
personal information provided. Please see the Privacy Act heading 
below.

Public Participation and Request for Comments

    If you submit a comment, please include the docket number for this 
notice (FMCSA-2026-0760), indicate the specific section of this 
document to which your comment applies, and provide a reason for each 
suggestion or recommendation. You may submit your comments and material 
online or by fax, mail, or hand delivery, but please use only one of 
these means. FMCSA recommends that you include your name and a mailing 
address, an email address, or a phone number in the body of your 
document so FMCSA can contact you if there are questions regarding your 
submission.
    To submit your comment online, go to <a href="https://www.regulations.gov/docket/FMCSA-2026-0760/document">https://www.regulations.gov/docket/FMCSA-2026-0760/document</a>, click on this notice, click 
``Comment,'' and type your comment into the text box on the following 
screen.
    If you submit your comments by mail or hand delivery, submit them 
in an unbound format, no larger than 8\1/2\ by 11 inches, suitable for 
copying and electronic filing.
    FMCSA will consider all comments and material received during the 
comment period.

Privacy Act

    In accordance with 5 United States Code (U.S.C.) 553(c), DOT 
solicits comments from the public to better inform its regulatory 
process. DOT posts these comments, including any personal information 
the commenter provides, to <a href="http://www.regulations.gov">www.regulations.gov</a> as described in the 
system of records notice DOT/ALL 14 (Federal Docket Management System 
(FDMS)), which can be reviewed at <a href="https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices">https://www.transportation.gov/individuals/privacy/privacy-act-system-records-notices</a>. The comments 
are posted without edits and are searchable by the name of the 
submitter.

Background

    FMCSA's primary mission is to reduce crashes, injuries, and 
fatalities involving large trucks and buses. The Secretary of 
Transportation has delegated to FMCSA its responsibility under 49 
U.S.C. 31136 and 31502 to prescribe regulations that ensure CMVs are 
operated safely. As part of this mission, the Agency's Medical Programs 
Division works to ensure that CMV drivers engaged in interstate 
commerce are physically qualified and able to safely perform their 
work.
    The public interest in, and right to have, safe highways requires 
the assurance that drivers of CMVs can safely perform the increased 
physical and mental demands of their duties. FMCSA's physical 
qualification standards provide this assurance by requiring drivers to 
be examined and medically certified as physically and mentally 
qualified to drive.
    The purpose of this voluntary IC is to assist the ME in determining 
if the driver is medically qualified under 49 Code of Federal 
Regulations (CFR) 391.41 and to ensure that there are no

[[Page 24959]]

disqualifying medical conditions that could adversely affect their safe 
driving ability or cause incapacitation constituting a risk to the 
public. Under 49 CFR 391.41(b)(12), a person is physically qualified to 
drive a CMV if that person does not use any drug or substance 
identified in 21 CFR 1308.11 Schedule I, an amphetamine, a narcotic, or 
other habit-forming drug; and does not use any non-Schedule I drug or 
substance that is identified in the other Schedules in 21 CFR part 1308 
except when the use is prescribed by a licensed medical practitioner, 
as defined in 49 CFR 382.107, who is familiar with the driver's medical 
history and has advised the driver that the substance will not 
adversely affect the driver's ability to safely operate a CMV.
    The use of this IC is at the discretion of the ME and facilitates 
communication with treating healthcare professionals who are 
responsible for prescribing certain medications so that the ME fully 
understands the reasons the medications have been prescribed. This 
information assists the ME in determining whether the underlying 
medical condition and the prescribed medication will impact the 
driver's safe operation of a CMV. Therefore, there is no required 
collection frequency.
    The ``391.41 CMV Driver Medication Form, MCSA-5895,'' may be 
downloaded from the FMCSA website. Prescribing healthcare providers are 
also able to either fax or scan and email the report to the certified 
ME. Consistent with OMB's commitment to minimizing respondents' 
recordkeeping and paperwork burdens and the increased use of secure 
electronic modes of communication, the Agency believes that 
approximately 50 percent of the ``391.41 CMV Driver Medication Forms, 
MCSA-5895,'' are transmitted electronically.
    The information collected from the ``391.41 CMV Driver Medication 
Form, MCSA-5895,'' is used by the certified ME that requested the 
completion of the form. The ``391.41 CMV Driver Medication Form, MCSA-
5895,'' is attached to the ``Medical Examination Report Form, MCSA-
5875,'' which becomes part of the CMV driver's record maintained by the 
certified ME. The information is not available to the public. The 
Federal Motor Carrier Safety Regulations covering driver physical 
qualification records are found at 49 CFR 391.43, which specify that a 
medical examination must be performed on CMV drivers subject to part 
391 who operate in interstate commerce. The results of the examination 
must be recorded in accordance with the requirements set forth in that 
section. MEs are required to maintain records of the CMV driver medical 
examinations they conduct.
    Title: 391.41 CMV Driver Medication Form.
    OMB Control Number: 2126-0064.
    Type of Request: Renewal of a currently approved ICR.
    Respondents: Prescribing healthcare professionals.
    Estimated Number of Respondents: Up to 1,470,185 (total number of 
prescribing healthcare providers in the U.S.).
    Estimated Time per Response: 8 minutes.
    Expiration Date: September 30, 2026.
    Frequency of Response: Other (use of this IC is optional so there 
is no required collection frequency).
    Estimated Total Annual Burden: 311,375 hours.
    Public Comments Invited: You are asked to comment on any aspect of 
this information collection, including: (1) whether the proposed 
collection is necessary for the performance of FMCSA's functions; (2) 
the accuracy of the estimated burden; (3) ways for FMCSA to enhance the 
quality, usefulness, and clarity of the collected information; and (4) 
ways that the burden could be minimized without reducing the quality of 
the collected information. The Agency will summarize or include your 
comments in the request for OMB's clearance of this ICR.
    Issued under the authority of 49 CFR 1.87.

David M. Sutula,
Acting Associate Administrator, Office of Research and Registration.
[FR Doc. 2026-08992 Filed 5-6-26; 8:45 am]
BILLING CODE 4910-EX-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on May 7, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.